Mitchell P, O'Byrne KJ, Brown C, Jurkovic H, et al. A Randomized Phase 2 Trial of Nivolumab and Stereotactic Ablative Body Radiotherapy (SABR) in Advanced Non-Small Cell Lung Cancer, Progressing After First- or Second-Line Chemotherapy (NIVORAD). Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34700388